New EREG research could boost pancreatic cancer immunotherapy

A new study identifies the EREG protein as a potential key player in making pancreatic cancer more responsive to immunotherapy. Researchers believe EREG could alter the tumor microenvironment, helping treatments like CAR T-cell therapy work better against this hard-to-treat cancer.